DFTX
Definium Therapeutics Inc.

25,902
Mkt Cap
$1.67B
Volume
705,715.00
52W High
$18.70
52W Low
$4.70
PE Ratio
-8.59
DFTX Fundamentals
Price
$17.45
Prev Close
$16.95
Open
$17.05
50D MA
$15.19
Beta
1.82
Avg. Volume
2.28M
EPS (Annual)
-$1.54
P/B
9.96
Rev/Employee
$0.00
$238.52
Loading...
Loading...

About

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
74

Frequently Asked Questions

What is Market Cap of Definium Therapeutics Inc.?
What is the 52-week high for Definium Therapeutics Inc.?
What is the 52-week low for Definium Therapeutics Inc.?
What is Definium Therapeutics Inc. stock price today?
What was Definium Therapeutics Inc. stock price yesterday?
What is the PE ratio of Definium Therapeutics Inc.?
What is the Price-to-Book ratio of Definium Therapeutics Inc.?
What is the 50-day moving average of Definium Therapeutics Inc.?
How many employees does Definium Therapeutics Inc. have?

Latest DFTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.